Seismic Therapeutic has dosed the first healthy participant cohort in the randomised Phase I trial of bifunctional antibody S ...

J&J has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in treating plaque ...

MaaT Pharma has reported positive results from an interim safety analysis of its Phase IIb trial of MaaT033 in subjects ...

Oculis has concluded subject enrolment for the Phase III clinical trials of OCS-01 eye drops for diabetic macular oedema.

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

Amylyx Pharmaceuticals has dosed the first subject in the Phase I LUMINA trial, investigating AMX0114, a potential treatment ...

Worldwide Clinical Trials (Worldwide) has introduced a new AI-driven tool for improving optimisation of studies.

Sarepta and Roche announced a 16-year-old US patient dosed with Elevidys died of acute liver failure in March 2025.

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to ...

The Lancet research papers build on the WHO’s Guidance for best practices in clinical trials released in September 2024.

One in three women will become pregnant after an MS diagnosis, therefore consideration of the maternal-infant dyad is needed.

LifeMine Therapeutics has dosed the first subject in the Phase I trial of calcineurin inhibitor (CNi), LIFE-001.